New joint paper in Cell Metabolism by the META-CAN principal investigators Catherine Thieblemont (AP-HP Hopital Saint-louis-Université Paris Descartes) and Jean-Ehrland Ricci (C3M, INSERM), with the participation of the ESR Manuel Grima-Reyes (C3M, INSERM).
META-CAN’s deputy coordinator, Jean-Ehrland Ricci has recently published a very relevant study on immunometabolism of cancer in Cell Metabolism. His work has identified a molecular pathway that leads to an enhanced anticancer immune response after protein dietary restriction.
📌@aromicsbiotech, among the 175+ European companies that will present its advances in the 3th edition of @TechTourHQ Contest Final to an international audience of 350+investors, key corporates &innovation experts ▶️https://t.co/hy204evuZG
fantastic work in @sciencemagazine from our own @bobdleone about glutamine antagonism in cancer. double-edged sword that suppresses tumor metabolism and increases functionality of the TIL. #immunotherapy #immunometabolism